Q2 2022 EPS Estimates for Omega Healthcare Investors, Inc. Decreased by Jefferies Financial Group (NYSE:OHI)

Omega Healthcare Investors, Inc. (NYSE:OHIGet Rating) – Research analysts at Jefferies Financial Group reduced their Q2 2022 earnings per share (EPS) estimates for shares of Omega Healthcare Investors in a report released on Thursday, April 14th. Jefferies Financial Group analyst J. Petersen now forecasts that the real estate investment trust will post earnings per share of $0.70 for the quarter, down from their prior estimate of $0.72. Jefferies Financial Group also issued estimates for Omega Healthcare Investors’ Q4 2022 earnings at $0.78 EPS, FY2022 earnings at $2.90 EPS, Q2 2023 earnings at $0.78 EPS, Q4 2023 earnings at $0.80 EPS and FY2023 earnings at $3.16 EPS.

Omega Healthcare Investors (NYSE:OHIGet Rating) last posted its quarterly earnings data on Wednesday, February 2nd. The real estate investment trust reported $0.14 EPS for the quarter, missing the Zacks’ consensus estimate of $0.79 by ($0.65). Omega Healthcare Investors had a net margin of 39.21% and a return on equity of 9.98%. The company had revenue of $214.31 million for the quarter, compared to analyst estimates of $235.47 million. During the same quarter in the prior year, the business earned $0.81 EPS. Omega Healthcare Investors’s revenue was down 4.4% compared to the same quarter last year.

Several other research analysts have also issued reports on OHI. Credit Suisse Group decreased their price target on shares of Omega Healthcare Investors from $31.00 to $28.00 and set a “neutral” rating on the stock in a research report on Tuesday, February 8th. StockNews.com began coverage on shares of Omega Healthcare Investors in a research report on Thursday, March 31st. They issued a “hold” rating on the stock. Raymond James decreased their price target on shares of Omega Healthcare Investors from $35.00 to $33.00 and set an “outperform” rating on the stock in a research report on Friday, March 18th. Mizuho decreased their price target on shares of Omega Healthcare Investors from $34.00 to $32.00 in a research report on Thursday, February 10th. Finally, Zacks Investment Research lowered shares of Omega Healthcare Investors from a “hold” rating to a “sell” rating in a research report on Wednesday, March 23rd. Two research analysts have rated the stock with a sell rating, six have assigned a hold rating and three have given a buy rating to the company’s stock. Based on data from MarketBeat.com, the company presently has a consensus rating of “Hold” and a consensus target price of $36.64.

Omega Healthcare Investors stock opened at $27.47 on Friday. The company has a debt-to-equity ratio of 1.28, a quick ratio of 3.24 and a current ratio of 3.24. The firm has a market cap of $6.57 billion, a price-to-earnings ratio of 15.52, a price-to-earnings-growth ratio of 6.09 and a beta of 0.96. Omega Healthcare Investors has a 1 year low of $26.92 and a 1 year high of $39.31. The firm’s 50 day moving average price is $28.84 and its two-hundred day moving average price is $29.34.

The company also recently disclosed a quarterly dividend, which was paid on Tuesday, February 15th. Investors of record on Monday, February 7th were paid a $0.67 dividend. This represents a $2.68 dividend on an annualized basis and a yield of 9.76%. The ex-dividend date of this dividend was Friday, February 4th. Omega Healthcare Investors’s dividend payout ratio is 151.41%.

Several large investors have recently modified their holdings of OHI. Norges Bank acquired a new stake in shares of Omega Healthcare Investors during the 4th quarter valued at $69,919,000. Deutsche Bank AG boosted its stake in shares of Omega Healthcare Investors by 402.2% during the 4th quarter. Deutsche Bank AG now owns 1,940,636 shares of the real estate investment trust’s stock valued at $57,423,000 after buying an additional 1,554,181 shares during the period. Bank of America Corp DE boosted its stake in shares of Omega Healthcare Investors by 659.5% during the 2nd quarter. Bank of America Corp DE now owns 1,461,584 shares of the real estate investment trust’s stock valued at $53,041,000 after buying an additional 1,269,147 shares during the period. Lasalle Investment Management Securities LLC acquired a new stake in shares of Omega Healthcare Investors during the 4th quarter valued at $36,158,000. Finally, Millennium Management LLC acquired a new stake in shares of Omega Healthcare Investors during the 3rd quarter valued at $36,569,000. 64.93% of the stock is owned by institutional investors.

Omega Healthcare Investors Company Profile (Get Rating)

Omega is a real estate investment trust that invests in the long-term healthcare industry, primarily in skilled nursing and assisted living facilities. Its portfolio of assets is operated by a diverse group of healthcare companies, predominantly in a triple-net lease structure. The assets span all regions within the US, as well as in the UK.

Featured Articles

Earnings History and Estimates for Omega Healthcare Investors (NYSE:OHI)

Receive News & Ratings for Omega Healthcare Investors Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Omega Healthcare Investors and related companies with MarketBeat.com's FREE daily email newsletter.